Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00100425
Collaborator
(none)
1
Study Details
Study Description
Brief Summary
The purpose of this study is to provide new information and to determine which kinds of brief, tolerable, experimental pain are affected by the drugs being studied in patients with irritable bowel syndrome, a disease that causes chronic abdominal pain. The effects of dextromethorphan, naloxone, and fentanyl on experimental pain stimuli will be tested in these studies to better understand what causes irritable bowel syndrome.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Diagnostic
Official Title:
Central Nervous System Modulation of Visceral Pain in Persian Gulf War Syndrome
Study Start Date
:
Sep 1, 2000
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 72 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
-
Patients with irritable bowel syndrome and healthy pain-free individuals (as controls) will be studied.
-
No medical condition that would contraindicate use of dextromethorphan, fentanyl or naloxone.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Malcolm Randall VA Medical Center | Gainesville | Florida | United States | 32608 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00100425
Other Study ID Numbers:
- CADE-ARCD2
First Posted:
Dec 31, 2004
Last Update Posted:
Jan 21, 2009
Last Verified:
Dec 1, 2004
Keywords provided by ,
,
Additional relevant MeSH terms: